Ethris adds three new members to board of directors

By 2016-07-19T12:00:00

German biotech firm Ethris GmbH has added three new members to the Ethris board of directors: Leon Chen, venture partner with OrbiMed, Thomas Chalberg, COO of Oncorus, and Justin Duckworth, managing partner with HS Life Sciences.

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.

Become a Member

News and analysis for the well-informed compliance or audit exec. Select an option and click continue.

Annual Membership $499 Value offer

Full price one year membership with auto-renewal.

Membership $599

One-year only, no auto-renewal.

Access CW Newsletters and CPE webcasts. REGISTER FOR LIMITED FREE ACCESS
Already a Compliance Week member?